NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 3, 2018 | Series Unknown | $20.03M | — | — | — | Detail |
Apr 29, 2016 | Series Unknown | $19.99M | — | — | — | Detail |
Apr 1, 2014 | Series B | $21M | 5 | Baird Capital Pfizer Venture Investments Venture Investors | — | Detail |
Apr 1, 2012 | Series A | $5M | 1 | Wolverine Venture Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Baird Capital | Yes | Series B |
Pfizer Venture Investments | Yes | Series B |
Venture Investors | Yes | Series B |
Arboretum Ventures | — | Series B |
Wolverine Venture Fund | — | Series B |